The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1428
ISSUE1428
October 28, 2013
Topiramate Extended-Release (Trokendi XR) for Epilepsy
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Topiramate Extended-Release (Trokendi XR) for Epilepsy
October 28, 2013 (Issue: 1428)
The FDA has approved a once-daily extended-release
(ER) formulation of the antiepileptic topiramate (Trokendi
XR – Supernus) for initial monotherapy in patients ≥10
years old with partial onset seizures or primary generalized
tonic-clonic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.